Profusa to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Core Insights - Profusa, Inc. is a commercial stage digital health company focused on continuous monitoring of individual biochemistry [1][2] - CEO Ben Hwang will present a corporate overview at the H.C. Wainwright 27th Annual Global Investment Conference from September 8-10, 2025 [1] - The presentation will be available on demand for registered investors starting September 5, 2025 [2] Company Overview - Profusa is based in Berkeley, California, and is led by a team of experienced management and a world-class board [2] - The company develops tissue-integrated sensors that provide actionable, medical-grade data for personal and medical use [2] - Profusa aims to offer long-lasting, injectable, and affordable biosensors along with an intelligent data platform to deliver personalized biochemical signatures [2]